Algo version: 0.98b
4basebio PLC is listed at the LSE Exchange
4basebio PLC [4BB.L]
LSE Sector: Healthcare Industry:Biotechnology

Is 4basebio PLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for 4basebio PLC 10 years ago, but if you had invested on Wednesday 17th of February 2021 when the price was GBP337.50, you would have made a profit of GBP1 062.50 per share or 314.81%

Yes, the average daily trading liquidity for 4basebio PLC is GBP1 716 thousand. You should therefore be able to get in and out of your positions relatively fast.

4basebio PLC has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for 4basebio PLC to be high [1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.